Skip to main content

iSpecimen, Inc. (ISPC)

NASDAQ: ISPC · IEX Real-Time Price · USD
17.51
7.31 (71.67%)
At close: Nov 26, 2021 1:00 PM
19.12
1.61 (9.19%)
After-hours:Nov 26, 2021 4:59 PM EST

Company Description

iSpecimen is technology-driven company founded to address a critical challenge: how to connect life science researchers who need human biofluids, tissues, and living cells (“biospecimens”) for their research, with the billions of biospecimens available (but not easily accessible) in healthcare provider organizations worldwide.

Our ground-breaking iSpecimen Marketplace platform was designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery.

The iSpecimen Marketplace brings new capabilities to a highly fragmented and inefficient biospecimen procurement market. Our technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them.

We are seeking to transform the world of biospecimen procurement much like the way travel websites changed the consumer buying process for flights, hotels, and rental cars.

iSpecimen, Inc.
CountryUnited States
Founded2009
IPO DateJun 17, 2021
IndustryDiagnostics & Research
SectorHealthcare
Employees41
CEOChristopher Ianelli

Contact Details

Address:
450 Bedford Street
Lexington, MA 02420
United States
Phone781 301 6700
Websiteispecimen.com

Stock Details

Ticker SymbolISPC
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
IPO Price$8.00
CIK Code1558569

Key Executives

NamePosition
Dr. Christopher J. Ianelli Ph.D., M.D.Founder, President, Chief Executive Officer and Director
Tracy Wilson CurleyChief Financial Officer
Jill MullanChief Operating Officer, Treasurer, Secretary and Director
Benjamin BielakChief Information Officer
Eric LangloisSenior Vice President of Sales and Business Development
Carly LejnieksVice President of Marketing
Emily HubbardVice President of Site Management and Development
David Wages M.D., Ph.D.Chief Medical Officer

Latest SEC Filings

DateTypeTitle
Nov 17, 20214Statement of changes in beneficial ownership of securities
Nov 4, 20218-KCurrent report
Nov 4, 202110-QQuarterly report [Sections 13 or 15(d)]
Aug 16, 20218-KCurrent report
Aug 10, 20218-KCurrent report
Aug 10, 202110-QQuarterly report [Sections 13 or 15(d)]
Jul 8, 2021SC 13GStatement of acquisition of beneficial ownership by individuals
Jul 1, 20218-KCurrent report
Jun 23, 20214Statement of changes in beneficial ownership of securities
Jun 23, 20214Statement of changes in beneficial ownership of securities
View All SEC Filings